Nanoparticle Albumin Bound Paclitaxel in the Third-Line Treatment of Recurrent Small Cell Lung Cancer in Real-World Practice: A Single Center Experience

Background: Small cell lung cancer (SCLC) is a type of highly malignant tumor. It is easy to relapse and high resistant to second-line chemotherapy. There is not a standard plan for third-line and subsequent-line treatment, hence the current study aimed to explore the performance of nanoparticle alb...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuchao, Li, Li, Xu, Chunhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642115/
https://www.ncbi.nlm.nih.gov/pubmed/34657492
http://dx.doi.org/10.1177/15330338211050775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642115/
https://www.ncbi.nlm.nih.gov/pubmed/34657492
http://dx.doi.org/10.1177/15330338211050775

Ejemplares similares